Did you mean: DONAHUE v. WYETH, INC. et al ?
Web Results

caselaw.findlaw.com/us-supreme-court/09-152.html

United States Supreme Court. BRUESEWITZ ET AL. v. WYETH LLC, FKA WYETH, INC., ET AL., (2011). No. 09-152. Argued: October 12, 2010 Decided: February 22, 2011. The National Childhood Vaccine Injury Act of 1986 (NCVIA or Act) created a no-fault compensation program to stabilize a vaccine market adversely ...

www.law.cornell.edu/supct/cert/09-152

Oct 12, 2010 ... After their daughter suffered severe health problems following a routine vaccination for diphtheria-tetanus-pertussis (“DTP”), Russell and Robalee Bruesewitz sued Wyeth, Inc., the manufacturer of the vaccine, alleging that Wyeth's DTP vaccine was outmoded and inadequately designed. In response, Wyeth ...

www.ageofautism.com/2010/07/show-me-that-vaccines-are-safe-the-importance-of-the-supreme-court-bruesewitz-v-wyeth.html

Jul 13, 2010 ... Wyeth, Inc., a case headed to the U. S. Supreme Court in September or October of 2010 which will answer the question of whether the National ...... by a divide and rule mechanism, whereby all those against the legislation were, conveniently for BLF et al, portrayed by the media as zealots and idiots, while ...

www.casemine.com/judgement/us/5914e457add7b049348ffb68

LSA–R.S. 9:2800.57 Louis M. Bograd, Center for Constitutional Litigation, P.C., Washington, DC, Terrence J. Donahue, Jr., Daniel J. McGlynn, McGlynn Glisson ... R.S. 9:2800.51, et seq. We need ... Wyeth, Inc., 657 F.3d 420, 423 (6th Cir.2011 ), cert. denied,––– U.S. ––––, 132 S.Ct. 2103, 182 L.Ed.2d 868 (2012); Mensing v .

www.law360.com/articles/449432/pfizer-lands-2-15b-settlement-from-teva-sun-over-protonix

Jun 12, 2013 ... Pfizer Inc. said Wednesday that it has reached a $2.15 billion settlement with generic-drug makers Teva Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. to resolve ... Teva Pharmaceuticals USA Inc. et al., case number 2:04-02355, in the U.S. District Court for the District of New Jersey.

www.law360.com/articles/353660/pfizer-sues-11-rivals-to-defend-pristiq-patent

Jun 25, 2012 ... Pfizer and its Wyeth LLC subsidiary filed complaints against a slew of companies, such as Teva Pharmaceuticals USA Inc., Mylan Pharmaceuticals Inc., Watson Laboratories Inc., accusing each of infringing its patent for Pristiq by filing abbreviated ... Breckenridge Pharmaceutical Inc. et al., Pfizer Inc. et al. v.

www.frosszelnick.com/ourlawyers/craig-s-mende

In a trademark case concerning the ENTREPRENEUR OF THE YEAR mark, the Firm won a motion to dismiss declaratory judgment action against one Ernst & Young ("E&Y") party for lack of personal jurisdiction, and won motion to transfer the action against the remaining E&Y parties and consolidate with E&Y's infringement ...

www.courtlistener.com/opinion/1394141/house-v-armour-of-america-inc

Oct 31, 1994 ... Utah Code Ann. § 78-15-6(2) (1992). Utah law recognizes three types of product defects: design defects, manufacturing flaws, and inadequate warnings regarding use. Grundberg v. Upjohn Co., 813 P.2d 89, 92 (Utah 1991); see also W. Page Keeton et al., Prosser & Keeton on the Law of Torts § 99, at 695 ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2709243

Apr 9, 2009 ... 293T cells were split and plated in a 12-well dish at a concentration of 3–4 ×105 cells per well in DMEM with 10% inactivated FBS (v/v) (Invitrogen, Inc. Carlsbad, CA) and 1% penicillin-streptomycin (v/v) (Invitrogen, Carlsbad, CA). Twenty-four hours post-plating, cells were transfected with 2μg of TxA-RBD, ...